<DOC>
	<DOCNO>NCT01386541</DOCNO>
	<brief_summary>This monocenter trial conduct obtain first data safety , tolerability , pharmacokinetics ( PK ) pharmacodynamics ( PD ) multiple ascend dos BYK324677 human . In addition , trial provide preliminary information possible influence sex , food intake , posology ( twice daily administration BYK324677 ) support plan drug development programme .</brief_summary>
	<brief_title>Multiple Ascending Dose Trial BYK324677 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Given write informed consent Healthy male female subject . Assessed healthy base screen examination include medical history , physical examination , blood pressure ( systolic ≤140 mmHg , diastolic ≤90 mmHg ) , pulse rate ( within 4595 bpm ) , ECG assessment , clinical laboratory result Body mass index ( BMI ) ≥18 ≤28 kg/m² , body weight ≥60 kg History current evidence specify disease History malignancy past 5 year Gain loss body weight 5 % within last 2 month use weightloss medication within last 3 month ECG abnormalities clinical relevance Suspected hypersensitivity trial medication Positive virology test indicate acute chronic infection Clinically relevant laboratory parameter outside specified range Use specify medication within certain time frame use certain comedications Abuse alcohol drug Dietary habit would prevent take standardised meal Female subject : positive pregnancy test ; lack medically reliable method contraception trial Donation blood Smoking within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>